Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adenosine A2A Receptor (A2AR)
100%
Therapeutic Target
100%
Diabetic Retinopathy
100%
Tumor Necrosis Factor-α
30%
Wild Mice
20%
Cell Tumor
20%
Diabetes
20%
Diabetic
20%
C-Raf
20%
Microglia
20%
Amadori-glycated Albumin
20%
Adenosine Receptor Signaling
20%
Inflammation
10%
Cell Death
10%
Inflammatory Response
10%
Risk Factors
10%
Vascular Function
10%
Hyperglycemia
10%
Exchange Protein Directly Activated by cAMP
10%
Ablation
10%
Retinal Abnormalities
10%
Adenosine A2A Receptor Antagonist
10%
Inflammatory Mediators
10%
Retinal Complications
10%
Neuronal Function
10%
Anti-inflammatory Properties
10%
Intercellular Adhesion molecule-1 (ICAM-1)
10%
ERK Pathway
10%
Microglial Cells
10%
Activated Microglia
10%
Protective Effect
10%
Retinal Cell Death
10%
Extracellular Signal-regulated Kinase
10%
Pharmacological Data
10%
Local Production
10%
Diabetes Distress
10%
Inflammatory Pathways
10%
Genetic Evidence
10%
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL)
10%
Neuroscience
Adenosine A2A Receptor
100%
Diabetic Retinopathy
100%
Microglia
40%
Necrosis
30%
Diabetes Mellitus
20%
Cell Death
20%
Cyclic Adenosine Monophosphate
20%
Glycosylated Albumin
20%
C-Raf
20%
Receptor Agonists
10%
Hyperglycemia
10%
TUNEL Assay
10%
Anti-Inflammatory
10%
Intercellular Adhesion Molecule 1
10%
Extracellular Signal-Regulated Kinases
10%
Antiporter
10%
Adenosine Receptor
10%
DNA Nucleotidylexotransferase
10%
Risk Factor
10%
Genetics
10%